Examining the gut bacteriome, virome, and mycobiome in glucose metabolism disorders: Are we on the right track
HUBERMAN: The logic then is by taking epitalin, You can mimic this peptide that's normally released from a nice, young, healthy pineal
Looking beyond the intervertebral disc: the need for behavioral assays in models of discogenic pain
Your journey doesn't end after the procedure
Cagrilintide, the second generation (2020s) Novo Nordisk took the Pramlintide concept and applied the same half-life extension strategy that they used with Semaglutide: Kept the proline substitutions (anti-amyloid) Added a C20 fatty diacid via a -Glu linker to a lysine residue, albumin binding Additionally stabilized the N- and C-terminal positions Result: Cagrilintide with a half-life of 6.6 days (vs 50 minutes for Pramlintide)
Interestingly, inhibition of the binding to IKK by using a peptide inhibitor reduced NF-B activity and thereby senescence in progeroid mice (88)